SpinChip Hs-cTnI Sample Type Validation

CompletedOBSERVATIONAL
Enrollment

180

Participants

Timeline

Start Date

April 12, 2024

Primary Completion Date

July 3, 2024

Study Completion Date

July 3, 2024

Conditions
Acute Myocardial Infarction
Interventions
DIAGNOSTIC_TEST

SpinChip hs-cTnI

SpinChip Platform, consisting of the SpinChip hs-cTnI test (self-contained cartridge) and SpinChip Analyzer (instrument)

Trial Locations (1)

1474

Akershus University hospital, Akershus Clinical Research Center (ACR), Lørenskog

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Aurevia

INDUSTRY

collaborator

University Hospital, Akershus

OTHER

lead

SpinChip Diagnostics ASA

INDUSTRY

NCT06453707 - SpinChip Hs-cTnI Sample Type Validation | Biotech Hunter | Biotech Hunter